Schedule 13D ownership disclosure

Orexigen Theraptcs

Security class unavailable · CUSIP: 686164302

Event date: 2019-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001567619-19-012686
Form type
SC 13D/A
Filer
BAUPOST GROUP LLC/MA
CIK
CIK 1061768
Filed
Jun 04, 2019
Reporting period
May 31, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub